Aficamten shows cardiac benefits over blood pressure drug metoprolol Analysts see potential for aficamten to replace beta-blocker drugs for treating HCM Cytokinetics plans to submit data to regulators ...

Cytokinetics aims to compete with a Bristol Myers Squibb heart drug projected to become a blockbuster seller, and the company’s value proposition is that its drug candidate has a potential safety edge ...

The U.S. Food and Drug Administration has approved Cytokinetics' oral drug to treat a rare heart condition, the company said ...

Wegovy is part of a class of drugs called GLP-1 Receptor Agonists. Taking a weight loss drug may also help reduce the risk of heart attack, stroke and cardiac death, data shows. Wegovy, a drug ...

The clearance is the first in Cytokinetics’ lengthy history and pits its drug Myqorzo against Bristol Myers’ Camzyos, which ...

“TY1 is the first exomer – a new class of drugs that address tissue damage in unexpected ways.” TY1 has the structure of existing RNA drugs, and works like its natural version – amplifying the ...

Cytokinetics Inc. won US approval for a drug to treat a deadly heart condition, posing a potential threat to sales of a ...

Internal organ tissues often don’t heal after illness or injury and lose some function, such as the heart after a heart attack. UCLA cardiologists have identified a protein that interferes with ...

CHARLESTOWN, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular ...

This little pill — taken by adults and children alike — might just be a prescription for heart disease. Speaking to The Post, the veteran heart doctor tackled a drug that is commonly prescribed to ...